Recruitment has commenced for the RAPID -1 DFU Phase 2b randomised controlled clinical trial to investigate the safety and efficacy of the RAPID™ Biodynamic Haematogel treatment for patients with chronic diabetic foot ulcers in comparison with usual and customary care.
All regulatory approvals secured [MHRA, REC, NIHR, HRA] and recruitment commenced.
Trial details to be published in leading Journals.